T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $164B
1-Year Est. Return 17.05%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Quarter Est. Return
1 Year Est. Return
+17.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
+$7.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
751
New
Increased
Reduced
Closed

Top Buys

1 +$968M
2 +$909M
3 +$698M
4
NI icon
NiSource
NI
+$674M
5
BDX icon
Becton Dickinson
BDX
+$621M

Top Sells

1 +$1.72B
2 +$1.06B
3 +$767M
4
MCK icon
McKesson
MCK
+$766M
5
AVGO icon
Broadcom
AVGO
+$764M

Sector Composition

1 Technology 29.18%
2 Healthcare 18.36%
3 Consumer Discretionary 13.25%
4 Industrials 10.53%
5 Financials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNA icon
651
Snap-on
SNA
$18.1B
$417K ﹤0.01%
1,338
+211
ACN icon
652
Accenture
ACN
$165B
$408K ﹤0.01%
1,364
+444
PAYX icon
653
Paychex
PAYX
$40.3B
$396K ﹤0.01%
2,717
+88
MIDD icon
654
Middleby
MIDD
$6.36B
$317K ﹤0.01%
2,198
-329
IOVA icon
655
Iovance Biotherapeutics
IOVA
$873M
$314K ﹤0.01%
182,436
-1,747,584
CVS icon
656
CVS Health
CVS
$96B
$178K ﹤0.01%
+2,568
EW icon
657
Edwards Lifesciences
EW
$50B
$164K ﹤0.01%
+2,090
TTC icon
658
Toro Company
TTC
$6.97B
$162K ﹤0.01%
2,282
-30,160
REGN icon
659
Regeneron Pharmaceuticals
REGN
$75.5B
$152K ﹤0.01%
+288
BMY icon
660
Bristol-Myers Squibb
BMY
$106B
$145K ﹤0.01%
+3,113
VRTX icon
661
Vertex Pharmaceuticals
VRTX
$116B
$133K ﹤0.01%
+297
SNY icon
662
Sanofi
SNY
$120B
$83K ﹤0.01%
+1,707
AZN icon
663
AstraZeneca
AZN
$280B
$64K ﹤0.01%
+913
ICUI icon
664
ICU Medical
ICUI
$3.52B
$46K ﹤0.01%
+343
TEVA icon
665
Teva Pharmaceuticals
TEVA
$32.7B
$39K ﹤0.01%
+2,299
ENOV icon
666
Enovis
ENOV
$1.55B
$38K ﹤0.01%
1,202
-6,206,566
ONC
667
BeOne Medicines Ltd
ONC
$35.7B
$35K ﹤0.01%
+143
PFE icon
668
Pfizer
PFE
$148B
$33K ﹤0.01%
+1,354
MLTX icon
669
MoonLake Immunotherapeutics
MLTX
$1.06B
$25K ﹤0.01%
+509
PODD icon
670
Insulet
PODD
$21.4B
$25K ﹤0.01%
+79
ZLAB icon
671
Zai Lab
ZLAB
$2.16B
$25K ﹤0.01%
+713
DXCM icon
672
DexCom
DXCM
$25.5B
$22K ﹤0.01%
+243
APGE icon
673
Apogee Therapeutics
APGE
$5.24B
$21K ﹤0.01%
+464
MRNA icon
674
Moderna
MRNA
$10.8B
$19K ﹤0.01%
+681
ETNB
675
DELISTED
89bio
ETNB
$10K ﹤0.01%
+974